Kinetics of human butyrylcholinesterase inhibition by 1,9-dimethyl-methylene blue
Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disorder, characterized by β-amyloid plaques, neurofibrillary tangles and loss of cholinergic neurons. Butyrylcholinesterase (BChE) inhibition is one of the most critical strategy for the treatment of AD since BChE causes...
Main Author: | Kevser BIBEROGLU |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkish Chemical Society
2021-05-01
|
Series: | Journal of the Turkish Chemical Society, Section A: Chemistry |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/pub/jotcsa/issue/60129/853598 |
Similar Items
-
Towards Asymmetrical Methylene Blue Analogues: Synthesis and Reactivity of 3-<i>N</i>′-Arylaminophenothiazines
by: Alena Khadieva, et al.
Published: (2022-05-01) -
Comparative Study Regarding the Properties of Methylene Blue and Proflavine and Their Optimal Concentrations for In Vitro and In Vivo Applications
by: Maria-Eliza Nedu, et al.
Published: (2020-04-01) -
Arylamine Analogs of Methylene Blue: Substituent Effect on Aggregation Behavior and DNA Binding
by: Alena Khadieva, et al.
Published: (2021-05-01) -
Thermostabilisation of human serum butyrylcholinesterase for detection of its inhibitors in water and biological fluids
by: Lakshmanan Jaganathan, et al.
Published: (1999-01-01) -
Occurrence of butyrylcholinesterase polymorphisms in patients undergoing surgery in Slovakia
by: Lukáš Čuchráč, et al.
Published: (2023-05-01)